Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

2013 Alzheimer's disease facts and figures

Thies, W. H., & Bleiler, L. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,372

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630

Neurodegenerative Diseases Target Large-Scale Human Brain Networks

Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350

Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845

Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722

Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils

Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W.-M., Mattson, M. P., & Tycko, R. (2005) · Science · doi:10.1126/science.1105850 · Cited by 1,687

Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death

Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569

Tau in physiology and pathology

Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251

Proteopathic tau seeding predicts tauopathy in vivo

Holmes, B. B., Furman, J. L., Mahan, T. E., Yamasaki, T. R., Mirbaha, H., Eades, W. C., Belaygorod, L., Cairns, N. J., Holtzman, D. M., & Diamond, M. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411649111 · Cited by 696

Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo

Stancu, I.-C., Cremers, N., Vanrusselt, H., Couturier, J., Vanoosthuyse, A., Kessels, S., Lodder, C., Brône, B., Huaux, F., Octave, J.-N., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-01957-y · Cited by 447

Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies

Polanco, J. C., Li, C., Bodea, L., Martínez‐Mármol, R., Meunier, F. A., & Götz, J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.162 · Cited by 386

The complexity of tau in Alzheimer’s disease

Naseri, N. N., Wang, H., Guo, J. D., Sharma, M., & Luo, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.022 · Cited by 393

Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease

Simon, M. J., & Iliff, J. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.014 · Cited by 349

Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage

Shafiei, S. S., Guerrero-Muñoz, M. J., & Castillo-Carranza, D. L. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00083 · Cited by 314

Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes

Zuroff, L. R., Daley, D. A., Black, K. L., & Koronyo‐Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 292

Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases

Schoch, K. M., & Miller, T. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.010 · Cited by 274

Role of tau protein in Alzheimer’s disease: The prime pathological player

Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.327 · Cited by 278

Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory

Fà, M., Puzzo, D., Piacentini, R., Staniszewski, A., Zhang, H., Baltrons, M. A., Puma, D. D. L., Chatterjee, I., Li, J., Saeed, F., et al. (2016) · Scientific Reports · doi:10.1038/srep19393 · Cited by 290

Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner

Polanco, J. C., Scicluna, B. J., Hill, A. F., & Götz, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.709485 · Cited by 280

Ocular indicators of Alzheimer’s: exploring disease in the retina

Hart, N. J., Koronyo, Y., Black, K. L., & Koronyo‐Hamaoui, M. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1613-6 · Cited by 264

Tau Proteins and Tauopathies in Alzheimer’s Disease

Chong, F. P., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0574-1 · Cited by 260

Four-repeat tauopathies

Rösler, T. W., Marvian, A. T., Brendel, M., Nykänen, N.-P., Höllerhage, M., Schwarz, S. C., Hopfner, F., Koeglsperger, T., Respondek, G., Schweyer, K., et al. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101644 · Cited by 231

Cell type‐specific roles of APOE4 in Alzheimer disease

Blumenfeld, J., Yip, O., Kim, M. J., & Huang, Y. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00776-9 · Cited by 202

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu, E., Zhang, Y., & Wang, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 241

Traumatic Brain Injury Induces Tau Aggregation and Spreading

Edwards, G., Zhao, J., Dash, P. K., Soto, C., & Moreno-Gonzalez, I. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2018.6348 · Cited by 195

Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy

Luca, C. M. G. D., Elia, A. E., Portaleone, S. M., Cazzaniga, F. A., Rossi, M., Bistaffa, E., Cecco, E. D., Narkiewicz, J., Salzano, G., Carletta, O., et al. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0164-x · Cited by 190

Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons

Polanco, J. C., Li, C., Durisic, N., Sullivan, R., & Götz, J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0514-4 · Cited by 185

BIN1 favors the spreading of Tau via extracellular vesicles

Crotti, A., Sait, H. R., McAvoy, K. M., Estrada, K., Ergun, A., Szak, S., Marsh, G., Jandreski, L., Peterson, M., Reynolds, T. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45676-0 · Cited by 171

The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis

Buccellato, F. R., D’Anca, M., Serpente, M., Arighi, A., & Galimberti, D. (2022) · Biomedicines · doi:10.3390/biomedicines10092261 · Cited by 190

C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death

Kanmert, D., Cantlon, A., Muratore, C., Jin, M., O’Malley, T. T., Lee, G. S., Young‐Pearse, T. L., Selkoe, D. J., & Walsh, D. M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0387-15.2015 · Cited by 169

The “glymphatic” mechanism for solute clearance in Alzheimer's disease: game changer or unproven speculation?

Smith, A. J., & Verkman, A. S. (2017) · The FASEB Journal · doi:10.1096/fj.201700999 · Cited by 162

Passive immunotherapies targeting Aβ and tau in Alzheimer's disease

Plotkin, S. S., & Cashman, N. R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105010 · Cited by 161

Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models

Sankaranarayanan, S., Barten, D. M., Vana, L., Devidze, N., Yang, L., Cadelina, G. W., Hoque, N., DeCarr, L. B., Keenan, S., Lin, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125614 · Cited by 150

Therapy and clinical trials in frontotemporal dementia: past, present, and future

Tsai, R. M., & Boxer, A. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13640 · Cited by 157

Induction of a transmissible tau pathology by traumatic brain injury

Zanier, E. R., Bertani, I., Sammali, E., Pischiutta, F., Chiaravalloti, M. A., Vegliante, G., Masone, A., Corbelli, A., Smith, D. H., Menon, D. K., et al. (2018) · Brain · doi:10.1093/brain/awy193 · Cited by 136

Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol

Polanco, J. C., Hand, G. R., Briner, A., Li, C., & Götz, J. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02254-3 · Cited by 134

Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's DiseasesPreprint

Braak, H., & Tredici, K. D. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023630 · Cited by 132

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia

Das, R. R., Balmik, A. A., & Chinnathambi, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1694-y · Cited by 130

A physics-based model explains the prion-like features of neurodegeneration in Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Weickenmeier, J., Jucker, M., Goriely, A., & Ellen Kuhl, A. (2018) · Journal of the Mechanics and Physics of Solids · doi:10.1016/j.jmps.2018.10.013 · Cited by 126

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies

Perea, J. R., Llorens-Martín, M., Ávila, J., & Bolós, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00172 · Cited by 129

Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122

The APOE-R136S mutation protects against APOE4-driven tau pathology, neurodegeneration, and neuroinflammation

Nelson, M. R., Liu, P., Agrawal, A., Yip, O., Blumenfeld, J., Traglia, M., Kim, M. J., Koutsodendris, N., Rao, A., Grone, B., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01480-8 · Cited by 120

Mechanistic insight into sevoflurane-associated developmental neurotoxicity

Sun, M., Xie, Z., Zhang, J., & Leng, Y. (2021) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09677-y · Cited by 118

Extracellular Monomeric Tau Is Internalized by Astrocytes

Perea, J. R., López, E., Díez-Ballesteros, J. C., Ávila, J., Hernández, F., & Bolós, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00442 · Cited by 114

Distinct Therapeutic Mechanisms of Tau Antibodies

Funk, K. E., Mirbaha, H., Jiang, H., Holtzman, D. M., & Diamond, M. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657924 · Cited by 111

Antisense drugs make sense for neurological diseases

Bennett, C. F., Kordasiewicz, H. B., & Cleveland, D. W. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023738 · Cited by 108

Structure and Mechanism of Action of Tau Aggregation Inhibitors

Cisek, K. K., Cooper, G., Huseby, C. J., & Kuret, J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141107150331 · Cited by 98

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry

Furman, J. L., Holmes, B. B., & Diamond, M. I. (2015) · Journal of Visualized Experiments · doi:10.3791/53205 · Cited by 104

Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers

Ugalde, C. L., Finkelstein, D. I., Lawson, V. A., & Hill, A. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13772 · Cited by 92

Development of early diagnosis of Parkinson's disease: Illusion or reality?

Ugrumov, M. V. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13429 · Cited by 90

Invited review: Animal models of tauopathies and their implications for research/translation into the clinic

Dujardin, S., Colin, M., & Buée, L. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12200 · Cited by 101

Aβ plaques

Walker, L. C. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3025 · Cited by 113

Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's Disease

Kim, T. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0325-7 · Cited by 85

Sleep-Wake Cycle in Alzheimer’s Disease Is Associated with Tau Pathology and Orexin Dysregulation

Liguori, C., Spanetta, M., Izzi, F., Franchini, F., Nuccetelli, M., Sancesario, G. M., Santo, S. G. D., Bernardini, S., Mercuri, N. B., & Placidi, F. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191124 · Cited by 84

Bacterial DNA promotes Tau aggregation

Tetz, G. V., Pinho, M. A., Pritzkow, S., Méndez, N., Soto, C. A., & Tetz, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-59364-x · Cited by 81

Contribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau

Hudák, A., Kúsz, E., Domonkos, I., Jósvay, K., Kodamullil, A. T., Szilák, L., Hofmann‐Apitius, M., & Letoha, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-53038-z · Cited by 87

Extracellular Tau Oligomers Induce Invasion of Endogenous Tau into the Somatodendritic Compartment and Axonal Transport Dysfunction

Swanson, E., Breckenridge, L., McMahon, L. P., Som, S., McConnell, I., & Bloom, G. S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170168 · Cited by 76

Protein assembly systems in natural and synthetic biology

Chiesa, G., Kiriakov, S., & Khalil, A. S. (2020) · BMC Biology · doi:10.1186/s12915-020-0751-4 · Cited by 76

Dysfunction of the Blood-Brain Barrier—A Key Step in Neurodegeneration and Dementia

Noe, C. R., Noe-Letschnig, M., Handschuh, P. A., Noe, C. A., & Lanzenberger, R. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00185 · Cited by 76

A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies

Imbimbo, B. P., Ippati, S., Watling, M., & Balducci, C. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12453 · Cited by 76

Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system

Lopes, D. M., Llewellyn, S. K., & Harrison, I. F. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00293-2 · Cited by 75

Molecular Mechanisms in the Pathogenesis of Alzheimer’s disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation

Hasegawa, M. (2016) · Biomolecules · doi:10.3390/biom6020024 · Cited by 75

Progression of Alzheimer’s disease, tau propagation, and its modifiable risk factors

Takeda, S. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.08.005 · Cited by 75

The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties

Matsumoto, S.-E., Motoi, Y., Ishiguro, K., Tabira, T., Kametani, F., Hasegawa, M., & Hattori, N. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv351 · Cited by 66

The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration

Deger, J. M., Gerson, J. E., & Kayed, R. (2015) · Aging Cell · doi:10.1111/acel.12359 · Cited by 69

Prions: Generation and Spread Versus Neurotoxicity

Halliday, M., Radford, H., & Mallucci, G. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.568477 · Cited by 68

Comorbidities of HIV infection

Sviridov, D., Mukhamedova, N., Makarov, A. А., Adzhubei, A. A., & Bukrinsky, M. (2019) · AIDS · doi:10.1097/qad.0000000000002385 · Cited by 69

Normal and Pathological Tau Uptake Mediated by M1/M3 Muscarinic Receptors Promotes Opposite Neuronal Changes

Morozova, V., Cohen, L. S., Makki, A. E.-H., Shur, A., Pilar, G. R., Idrissi, A. E., & Alonso, A. D. C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00403 · Cited by 67

Reactive Astrocytes as Drug Target in Alzheimer’s Disease

Assefa, B. T., Gebre, A. K., & Altaye, B. M. (2018) · BioMed Research International · doi:10.1155/2018/4160247 · Cited by 66

Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization

Shirafuji, N., Hamano, T., Yen, S.-H. C., Kanaan, N. M., Yoshida, H., Hayashi, K., Ikawa, M., Yamamura, O., Kuriyama, M., & Nakamoto, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030891 · Cited by 59

Major Differences between the Self-Assembly and Seeding Behavior of Heparin-Induced and in Vitro Phosphorylated Tau and Their Modulation by Potential Inhibitors

Despres, C., Di, J., Cantrelle, F., Li, Z., Huvent, I., Chambraud, B., Zhao, J., Chen, J., Chen, S., Lippens, G. M., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00325 · Cited by 61

Differences Between Human and Murine Tau at the N-terminal End

Hernández, F., Merchán‐Rubira, J., Vallés‐Saiz, L., Rodríguez-Matellán, A., & Ávila, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00011 · Cited by 64

Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model

Lopes, D. M., Wells, J. A., Ma, D., Wallis, L., Park, D., Llewellyn, S. K., Ahmed, Z., Lythgoe, M. F., & Harrison, I. F. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01439-2 · Cited by 57

Prions: What Are They Good For?

Si, K. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013409 · Cited by 57

Huntington’s disease cerebrospinal fluid seeds aggregation of mutant huntingtin

Tan, Z., Dai, W., van Erp, T. G. M., Overman, J., Demuro, A., Digman, M. A., Hatami, A., Albay, R., Sontag, E. M., Potkin, K. T., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.81 · Cited by 57

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease

Gunnarsson, M. D., Ingelsson, M., Blennow, K., Basun, H., Lannfelt, L., & Kilander, L. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0191-0 · Cited by 55

Dephosphorylated rather than hyperphosphorylated Tau triggers a pro-inflammatory profile in microglia through the p38 MAPK pathway

Perea, J. R., Ávila, J., & Bolós, M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.08.007 · Cited by 54

Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans

Weisová, P., Cehlár, O., Škrabana, R., Žilková, M., Filipčík, P., Kováčech, B., Prčina, M., Wojčiaková, Ľ., Fialová, Ľ., Smolek, T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0770-y · Cited by 53

Heparan Sulfate Proteoglycans Undergo Differential Expression Alterations in Alzheimer Disease Brains

Lorente-Gea, L., García, B., Martín, C., Ordiales, H., García‐Suárez, O., Batista, K. M. P., Merayo-Llovés, J., Quirós, L. M., & Fernández‐Vega, I. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa016 · Cited by 49

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease

Aillaud, I., & Funke, S. A. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01230-7 · Cited by 51

Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease

Dammers, C., Yolcu, D., Kukuk, L., Willbold, D., Pickhardt, M., Mandelkow�, E., Horn, A. H. C., Sticht, H., Malhis, M., Will, N., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167432 · Cited by 50

Chemicals used for the induction of Alzheimer’s disease-like cognitive dysfunctions in rodents

Mahdi, O., Baharuldin, M. T. H., Nor, N. H. M., Chiroma, S. M., Jagadeesan, S., & Moklas, M. A. M. (2019) · Biomedical Research and Therapy · doi:10.15419/bmrat.v6i11.575 · Cited by 53

Prions: generation and spread versus neurotoxicity.

Halliday, M., Radford, H. E., & Mallucci, G. R. (2014) · Figshare · doi:10.17863/cam.14500 · Cited by 48

Alzheimer’s disease AdvaxCpG- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules

Davtyan, H., Zagorski, K., Rajapaksha, H., Hovakimyan, A., Davtyan, A., Petrushina, I., Kazarian, K., Cribbs, D. H., Petrovsky, N., Agadjanyan, M. G., et al. (2016) · Scientific Reports · doi:10.1038/srep28912 · Cited by 47

Prions and Prion-like Proteins

Fraser, P. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.583492 · Cited by 48

Neuropathology of the Alzheimer's continuum: an update

Jellinger, K. A. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3050 · Cited by 52

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Almeida, Z. L., Vaz, D. C., & Brito, R. M. M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04543-4 · Cited by 49

Distinct C9orf72-Associated Dipeptide Repeat Structures Correlate with Neuronal Toxicity

Flores, B. N., Dulchavsky, M. E., Krans, A., Sawaya, M. R., Paulson, H. L., Todd, P. K., Barmada, S. J., & Ivanova, M. I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165084 · Cited by 42

Invited review: Drug development for tauopathies

Grüninger, F. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12192 · Cited by 40

Reversible Cation-Selective Attachment and Self-Assembly of Human Tau on Supported Brain Lipid Membranes

Mari, S. A., Wegmann, S., Tepper, K., Hyman, B. T., Mandelkow, E., Mandelkow�, E., & Müller, D. J. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01085 · Cited by 39

Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish

Naini, S. M. A., & Soussi‐Yanicostas, N. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00163 · Cited by 39

Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake

La‐Rocque, S. D., Moretto, E., Butnaru, I., & Schiavo, G. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15144 · Cited by 46

Critical Molecular and Cellular Contributors to Tau Pathology

Song, L., Wells, E. A., & Robinson, A. S. (2021) · Biomedicines · doi:10.3390/biomedicines9020190 · Cited by 40

Recent Insights on Alzheimer’s Disease Originating from Yeast Models

Seynnaeve, D., Vecchio, M. D., Fruhmann, G., Verelst, J., Cools, M., Beckers, J., Mulvihill, D. P., Winderickx, J., & Franssens, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071947 · Cited by 39

Three-Dimensional Collagen Type I Matrix Up-Regulates Nuclear Isoforms of the Microtubule Associated Protein Tau Implicated in Resistance to Paclitaxel Therapy in Ovarian Carcinoma

Main, H. G., Yu, Y., Choi, J. J., Kajdacsy‐Balla, A., & Barbolina, M. V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023419 · Cited by 37

Pseudomonas aeruginosa exoenzymes U and Y induce a transmissible endothelial proteinopathy

Morrow, K. A., Ochoa, C. D., Balczon, R., Zhou, C., Cauthen, L., ALEXEYEV, M. F., Schmalzer, K. M., Frank, D. W., & Stevens, T. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00103.2015 · Cited by 37

Pioglitazone prevents tau oligomerization

Hamano, T., Shirafuji, N., Makino, C., Yen, S.-H. C., Kanaan, N. M., Ueno, A., Suzuki, J., Ikawa, M., Matsunaga, A., Yamamura, O., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.016 · Cited by 37

Frontrunner in Translation: Progressive Supranuclear Palsy

Shoeibi, A., Olfati, N., & Litvan, I. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01125 · Cited by 39

Cellular mechanisms responsible for cell-to-cell spreading of prions

Vilette, D., Courte, J., Peyrin, J., Coudert, L., Schaeffer, L., Andréoletti, O., & Leblanc, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2823-y · Cited by 43

Application of yeast to studying amyloid and prion diseases

Chernoff, Y. O., Grizel, A. V., Rubel, A. A., Zelinsky, A. А., Chandramowlishwaran, P., & Chernova, T. A. (2020) · Advances in genetics · doi:10.1016/bs.adgen.2020.01.002 · Cited by 41

Pathological Alterations of Tau in Alzheimer’s Disease and 3xTg-AD Mouse Brains

Li, L., Jiang, Y., Hu, W. H., Tung, Y. C., Dai, C., Chu, D., Gong, C., Iqbal, K., & Liu, F. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1507-4 · Cited by 36

In vivo network models identify sex differences in the spread of tau pathology across the brain

Shokouhi, S., Taylor, W. D., Albert, K., Kang, H., Newhouse, P. A., & Initiative, T. A. D. N. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12016 · Cited by 35

The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates

Moretto, E., Stuart, S., Surana, S., Vargas, J. N. S., & Schiavo, G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.844211 · Cited by 32

Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy

Huuskonen, M. T., Loppi, S. H., Dhungana, H., Keksa-Goldsteine, V., Lemarchant, S., Korhonen, P., Wojciechowski, S., Pollari, E., Valonen, P. K., Koponen, J., et al. (2016) · Scientific Reports · doi:10.1038/srep33176 · Cited by 34

Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns

Asher, D. M., Belay, E. D., Bigio, E. H., Brandner, S., Brubaker, S. A., Caughey, B. W., Clark, B., Damon, I. K., Diamond, M. I., Freund, M. P., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa109 · Cited by 35

How the formation of amyloid plaques and neurofibrillary tangles may be related: a mathematical modelling study

Kuznetsov, I. A., & Kuznetsov, A. V. (2018) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2017.0777 · Cited by 32

Effects of Intrinsic and Extrinsic Factors on Aggregation of Physiologically Important Intrinsically Disordered Proteins

Breydo, L., Redington, J., & Uversky, V. N. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.011 · Cited by 29

Is tau ready for admission to the prion club?

Hall, G. F., & Patuto, B. A. (2012) · Prion · doi:10.4161/pri.19912 · Cited by 43

Propagation of Tau Misfolding from the Outside to the Inside of a Cell

Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252

Prion-like Mechanisms in the Pathogenesis of Tauopathies and Synucleinopathies

Goedert, M., Falcon, B., Clavaguera, F., & Tolnay, M. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0495-z · Cited by 152

Prion-like properties of assembled TDP-43

Nonaka, T., & Hasegawa, M. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.018 · Cited by 28

Neurodegeneration‐related amyloids interact with the prion protein

Cecco, E. D., Narkiewicz, J., Grandolfo, M., Parisse, P., & Legname, G. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.464.3